Keskin, S. Et Al. 2019. Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.. Oncology research and treatment , vol.42, no.3 , 101-106.

Keskin, S., Kucucuk, S., Ak, N., ATALAR, B., Sari, M., Sozen, H., ... Ibis, K.(2019). Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.. Oncology research and treatment , vol.42, no.3, 101-106.

Keskin, Serkan Et Al. "Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.," Oncology research and treatment , vol.42, no.3, 101-106, 2019

Keskin, Serkan Et Al. "Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.." Oncology research and treatment , vol.42, no.3, pp.101-106, 2019

Keskin, S. Et Al. (2019) . "Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.." Oncology research and treatment , vol.42, no.3, pp.101-106.

@article{article, author={Serkan Keskin Et Al. }, title={Survival Impact of Optimal Surgical Cytoreduction in Recurrent Epithelial Ovarian Cancer with Brain Metastasis.}, journal={Oncology research and treatment}, year=2019, pages={101-106} }